A follow-up comparative safety analysis of pandemic H1N1 vaccination during pregnancy and risk of infant birth defects among U.S. military mothers
- PMID: 29625766
- DOI: 10.1016/j.vaccine.2018.03.061
A follow-up comparative safety analysis of pandemic H1N1 vaccination during pregnancy and risk of infant birth defects among U.S. military mothers
Abstract
Objective: To update a previous assessment of birth defects among infants born to active duty U.S. military mothers who received the 2009-2010 pandemic H1N1 vaccine, in comparison to the 2008-2009 seasonal influenza vaccine, during pregnancy. Here, we updated the previous comparative analyses with a more refined definition for birth defects using an additional year of follow-up data from both inpatient and outpatient medical encounters.
Methods: The study population included 15,510 live born infants born to active duty mothers vaccinated during pregnancy with either the 2009-2010 pandemic H1N1 vaccine (n = 9033) or the 2008-2009 seasonal influenza vaccine (n = 6477). Birth defect cases were defined as those infants who received a birth defect diagnosis on one inpatient record or two outpatient records on different days within the first year of life. Multivariable logistic regression models were conducted to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) for the association between birth defects and maternal vaccination during pregnancy with pandemic H1N1 vaccine versus seasonal influenza vaccine.
Results: Infants born to mothers vaccinated during pregnancy with the pandemic H1N1 vaccine, versus the seasonal influenza vaccine, were not at increased odds of birth defects in univariable (OR: 1.13, 95% CI: 0.95-1.34) or multivariable (OR: 1.14, 95% CI: 0.96-1.35) models. Findings were not significant when further limited to first trimester exposure. Multivariable models were adjusted for infant sex and plurality; maternal age, race/ethnicity, marital status, service branch, military rank, and occupation; timing of vaccination; and receipt of vaccination(s) not routinely recommended during pregnancy.
Conclusion: Comparable to our previous analyses assessing birth defects diagnosed at birth, no significant association was found between the pandemic H1N1 vaccination during pregnancy and birth defects, versus the seasonal influenza vaccine. These findings are reassuring and provide additional support for H1N1-containing seasonal influenza vaccination during pregnancy.
Keywords: Congenital abnormalities; Influenza vaccine; Maternal exposure; Military personnel; Pregnancy; Prenatal exposure delayed effects.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Safety of the pandemic H1N1 influenza vaccine among pregnant U.S. military women and their newborns.Obstet Gynecol. 2013 Mar;121(3):511-518. doi: 10.1097/AOG.0b013e318280d64e. Obstet Gynecol. 2013. PMID: 23635612
-
Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants.Vaccine. 2013 Oct 17;31(44):5026-32. doi: 10.1016/j.vaccine.2013.08.097. Epub 2013 Sep 7. Vaccine. 2013. PMID: 24016809
-
Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy.JAMA. 2012 Jul 11;308(2):165-74. doi: 10.1001/jama.2012.6131. JAMA. 2012. PMID: 22782418
-
Safety of influenza vaccination during pregnancy: a systematic review.BMJ Open. 2023 Sep 6;13(9):e066182. doi: 10.1136/bmjopen-2022-066182. BMJ Open. 2023. PMID: 37673449 Free PMC article.
-
Influenza vaccination in pregnancy: current evidence and selected national policies.Lancet Infect Dis. 2008 Jan;8(1):44-52. doi: 10.1016/S1473-3099(07)70311-0. Lancet Infect Dis. 2008. PMID: 18156088 Review.
Cited by
-
Atovaquone-proguanil exposure in pregnancy and risk for adverse fetal and infant outcomes: A retrospective analysis.Travel Med Infect Dis. 2019 Nov-Dec;32:101519. doi: 10.1016/j.tmaid.2019.101519. Epub 2019 Nov 17. Travel Med Infect Dis. 2019. PMID: 31747537 Free PMC article.
-
Influenza vaccination during pregnancy and risk of selected major structural noncardiac birth defects, National Birth Defects Prevention Study 2006-2011.Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):851-862. doi: 10.1002/pds.5435. Epub 2022 Apr 22. Pharmacoepidemiol Drug Saf. 2022. PMID: 35366035 Free PMC article.
-
Defining and reporting adverse events of special interest in comparative maternal vaccine studies: a systematic review.Vaccine X. 2024 Feb 23;18:100464. doi: 10.1016/j.jvacx.2024.100464. eCollection 2024 Jun. Vaccine X. 2024. PMID: 38495929 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical